In November 2020, two years after the first 3D colour X-ray of a human, MARS Bioimaging released new images generated with the innovative MARS compact scanner, based on the Medipix3 technology developed at CERN. The new images were part of a first demonstration that will lead to large-scale clinical trials taking place with the Pacific Radiology Group (New Zealand) and the Lausanne University Hospital (CHUV). Medipix is a family of read-out chips developed for particle imaging and detection. The MARS Bioimaging solution uses the spectroscopic information generated by Medipix3 to generate the 3D colour images. The colours represent different energy levels of X-ray photons recorded by the Medipix3 detector, identifying different body components such as fat, water, calcium, and disease markers